Edgewise Therapeutics (EWTX) Amortizatization of Intangibles (2022 - 2026)

Edgewise Therapeutics (EWTX) reported Amortizatization of Intangibles of $1.0 million for Q1 2026, up 2370.73% on a YoY basis from $41000.0 in Q1 2025, and down 31.69% sequentially from $1.5 million in Q4 2025.

Edgewise Therapeutics (EWTX) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Edgewise Therapeutics (EWTX) has 5 years of Amortizatization of Intangibles data on file, last reported at $1.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles rose 2370.73% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (up 399.07% YoY), and the FY2025 full-year result was $7.7 million, up 3368.33% from the prior year.
  • Amortizatization of Intangibles fell to $1.0 million in Q1 2026, from $1.5 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $9.4 million in Q4 2023 to a low of -$6.5 million in Q3 2024.
  • A 5-year average of $1.1 million and a median of $771000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • Across the five-year window, Amortizatization of Intangibles slumped 13712.5% in 2024 and soared 2751.92% in 2025, its largest moves.
  • Tracing EWTX's Amortizatization of Intangibles over 5 years: stood at $377000.0 in 2022, then surged by 2389.66% to $9.4 million in 2023, then sank by 99.45% to $52000.0 in 2024, then soared by 2751.92% to $1.5 million in 2025, then plunged by 31.69% to $1.0 million in 2026.
  • Business Quant data shows EWTX's Amortizatization of Intangibles at $1.0 million in Q1 2026, $1.5 million in Q4 2025, and $2.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Edgewise Therapeutics 4.46 Bn 4.46 Bn - 1.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.01 Mn
Mar 31, 2026 1.01 Mn
Dec 31, 2025 1.48 Mn
Dec 31, 2025 1.48 Mn
Sep 30, 2025 2.06 Mn
Sep 30, 2025 2.06 Mn
Jun 30, 2025 4.09 Mn
Jun 30, 2025 4.09 Mn
Mar 31, 2025 41,000.00
Mar 31, 2025 41,000.00
Dec 31, 2024 52,000.00
Dec 31, 2024 52,000.00
Sep 30, 2024 -6.53 Mn
Sep 30, 2024 -6.53 Mn
Jun 30, 2024 3.55 Mn
Jun 30, 2024 3.55 Mn
Mar 31, 2024 3.15 Mn
Mar 31, 2024 3.15 Mn
Dec 31, 2023 9.39 Mn
Dec 31, 2023 9.39 Mn